Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Blood (2024) 144 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2024-208191

Published: 2024

Journal Articles

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial

Blood (2024) 144 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2024-208486

Published: 2024

Journal Articles

Results from the Hemophilia Α Cohort of the Non-Investigational Lead-in Study: Prospective Collection of Bleeding Rate in Participants with Hemophilia Α Prior to Phase 3 Study (AFFINE) of Giroctocogene Fitelparvovec

Laurent Frenzel, Kaan Kavakli, Andrew D. Leavitt, Ali Bülent Antmen, Davide Matino, Margareth Ozelo, Hazza Alzahrani, Barbara A. Konkle, Maria de los Angeles Resa, Annie F. Fang, Jasmine Healy, Delphine Agathon, Francesca Biondo, Frank Plonski

Blood (2024) 144 (Supplement 1): 3575.

https://doi.org/10.1182/blood-2024-193368

Published: 2024

Journal Articles

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Blood (2024) 144 (Supplement 1): 409.

https://doi.org/10.1182/blood-2024-200867

Published: 2024

Journal Articles

Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Donatella Baronciani, Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Akif Yesilipek, Hasan Hashem, Gulyuz Ozturk, Franco Locatelli, Ali Alahmari, Javid Gaziev, Ali Bülent Antmen, O. Alphan Kupesiz, Tunc Fisgin, Giorgio La Nasa, Arjan C. Lankester, Eugene Goussetis, Sandrine Bremathas, Emanuele Angelucci

Blood (2024) 144 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2024-208421

Published: 2024

Journal Articles

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Blood (2024) 143 (22): 2256–2269.

https://doi.org/10.1182/blood.2023021864

Published: 2024

Includes: Supplemental data

Journal Articles

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Marco Aurelio Salvino, Bulent Antmen, Frederick Chite Asirwa, Satheesh Chonat, Lucia De Franceschi, Perla Eleftheriou, Adlette Inati, Johnny Mahlangu, Erfan Nur, Salvador Payán-Pernía, Asad Charania, Diana Gradinaru, Allison Hsia, Yves Luder, Thomas Perretti, Sasha Srekovic, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2023-179858

Published: 2023

Journal Articles

Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial

Robert F. Sidonio, Jr., Christine Knoll, Flora Peyvandi, Oleksandra Stasyshyn, Ali Bulent Antmen, Seoh Leng Yeoh, Darintr Sosothikul, Caterina Maggiore, Werner Engl, Geoffrey Allen, Srilatha Tangada

Blood (2021) 138 (Supplement 1): 3184.

https://doi.org/10.1182/blood-2021-146126

Published: 2021

Journal Articles

Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2017) 130 (Supplement 1): 4600.

https://doi.org/10.1182/blood.V130.Suppl_1.4600.4600

Published: 2017

Journal Articles

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, MD PhD, Pier Mannuccio Mannucci, MD, Isabella Garagiola, PhD, Mohsen Elalfy, MD, Amal El-Beshlawy, MD, Madatha V. Ramanan, MD, Peyman Eshghi, MD, Suresh Hanagavadi, Ramabadran Varadarajan, MD, Mehran Karimi, MD, Mamta V. Manglani, MD, Cecil Ross, MD, Guy Young, MD, Tulika Seth, MD, Shashikant Apte, MD FRCPA, Dinesh M. Nayak, MD, Adriana C. Sandoval Gonzales, MD, Elena Santagostino, MD PhD, Maria Elisa Mancuso, MD PhD, Johnny N. Mahlangu, MD, Santiago Bonanad, PhD, Monica Cerqueira, MD, Nadia P. Ewing, MD, Christoph Male, MD MSC, Tarek Owaidah, MD FRCPA, Veronica Soto Arellano, MD, Nathan L. Kobrinsky, MD FRCP, Suvankar Majumdar, MD, Rosario Perez Garrido, MD, Anupam Sachdeva, Mindy Simpson, MD FAAP, Mathew Thomas, Ezio Zanon, MD, ALI Bulent Antmen, Kaan Kavakli, MD, Marilyn Manco-Johnson, MD, Monica Martinez, MD, Esperanza Marzouka, MS, PS, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Angeles Palomo Bravo, MD, Rogelio Paredes Aguilera, MD, Alessandra Nunes Loureiro Prezotti, MD, Schmitt Klaus, MD, Brian M. Wicklund, MD MPH, Bulent Zulfikar, MD, Rosendaal R. Frits, MD PhD

Blood (2015) 126 (23): 5.

https://doi.org/10.1182/blood.V126.23.5.5

Published: 2015

Journal Articles

Micro-RNA Profile of Childhood Acute Lymphoblastic Leukemia

Barbaros Sahin Karagun, MD, Bulent Antmen, MD, Ilgen Sasmaz, MD, Kahraman Tanriverdi, PhD, Gulsum Ucar, PhD, Yurdanur Kilinc, MD

Blood (2012) 120 (21): 4824.

https://doi.org/10.1182/blood.V120.21.4824.4824

Published: 2012

Journal Articles

Effect of the Erythrocyte Apheresis On Immunological Parameters in Sickle Cell Anemia Patients in Crisis Period.

Yurdanur Kilinc, MD, Prof., Dr., Ferda Tekinturhan, BSc., Birol Guvenc, MD, Assoc., Prof., Dr., Refik Burgut, PhD, Prof., Dr., Ilgen Sasmaz, MD, Assoc., Prof., Dr., Bulent Antmen, MD, Prof., Dr.

Blood (2009) 114 (22): 4191.

https://doi.org/10.1182/blood.V114.22.4191.4191

Published: 2009

Journal Articles

The Eveluation of Pulmonary Functions in Children with Sickle Cell Anemia.

Cem Kurt, Ilgen Sasmaz, MD, Assoc., Prof., Dr., Bulent Antmen, MD, Prof., Dr., Yurdanur Kilinc, MD, Prof., Dr., Sadi Kurdak, Sedat Kuleci

Blood (2009) 114 (22): 4628.

https://doi.org/10.1182/blood.V114.22.4628.4628

Published: 2009

Journal Articles

The Serum Fas and Fas Ligand levels in Childhood Acute Leukemias.

Alev Kiziltas, Bulent Antmen, MD, Prof., Dr., Ilgen Sasmaz, MD, Assoc., Prof., Dr., Yurdanur Kilinc, MD, Prof., Dr., Mustafa Yilmaz, Akin Yigin

Blood (2009) 114 (22): 4724.

https://doi.org/10.1182/blood.V114.22.4724.4724

Published: 2009

Journal Articles

Management of Refractory Intracranial Hemorrhage in a Coagulopathic Patient with Liver Disease by Using Recombinant Factor VIIa (rFVIIa).

Goksel Leblebisatan, MD, Ilgen Sasmaz, MD, Kurthan Mert, MD, Ebru Ozates, MD, Bulent Antmen, MD, Yurdanur Kilinc, MD

Blood (2005) 106 (11): 4088.

https://doi.org/10.1182/blood.V106.11.4088.4088

Published: 2005

Journal Articles

Management of Refractory Hemorrhage in a Kala-Azar Patient with Thrombocytopenia and Coagulopathy by Using Recombinant Factor VIIa (rFVIIa).

Goksel Leblebisatan, MD, Ilgen Sasmaz, MD, Bulent Antmen, MD, Yurdanur Kilinc, MD, Umit Sizmaz Celik, MD, Kurthan Mert3, MD, Necmi Aksaray, MD

Blood (2005) 106 (11): 4090.

https://doi.org/10.1182/blood.V106.11.4090.4090

Published: 2005

Journal Articles

Successful Bilateral Cataract and Circumcision Operation Performed in a Hemophilia-A Patient with Inhibitors by Using Recombinant Factor VIIa.

Yurdanur Kilinc, MD, Ilgen Sasmaz, MD, Goksel Leblebistan, MD, Bulent Antmen, MD, Selcuk Sizmaz, MD, Meltem Yagmur, MD, Sibel Cayli, MD

Blood (2005) 106 (11): 4092.

https://doi.org/10.1182/blood.V106.11.4092.4092

Published: 2005

NARROW

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial

Results from the Hemophilia Α Cohort of the Non-Investigational Lead-in Study: Prospective Collection of Bleeding Rate in Participants with Hemophilia Α Prior to Phase 3 Study (AFFINE) of Giroctocogene Fitelparvovec

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial

Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Micro-RNA Profile of Childhood Acute Lymphoblastic Leukemia

Effect of the Erythrocyte Apheresis On Immunological Parameters in Sickle Cell Anemia Patients in Crisis Period.

The Eveluation of Pulmonary Functions in Children with Sickle Cell Anemia.

The Serum Fas and Fas Ligand levels in Childhood Acute Leukemias.

Management of Refractory Intracranial Hemorrhage in a Coagulopathic Patient with Liver Disease by Using Recombinant Factor VIIa (rFVIIa).

Management of Refractory Hemorrhage in a Kala-Azar Patient with Thrombocytopenia and Coagulopathy by Using Recombinant Factor VIIa (rFVIIa).

Successful Bilateral Cataract and Circumcision Operation Performed in a Hemophilia-A Patient with Inhibitors by Using Recombinant Factor VIIa.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only